ESR2 and ovarian cancer: All ovarian cancers displayed all three ERβ variants in the nucleus, and 93, 96 and 68% of samples showing cytoplasmic ERβ1, ERβ2, and ERβ5 staining, respectively (Figs. 1b and 2).